Top 100 Contractors in PSC 6550: In Vitro Diagnostic Substances, Reagents, Test Kits and Sets, FY2023

Parent companies by net contract obligations Oct 1, 2022 – Sep 30, 2023 Code page on GovTribe

The top 10 won 85% of FY2023 PSC 6550 contract dollars

Ranking facts

Contract obligations
$1,071,091,876 Net of deobligations, by contracts coded PSC 6550
Contractors
246 Parent companies with an obligation
Largest contractor
Abbott Laboratories $288 million, 25.4% of obligations
Data as of

Contract actions from FPDS (SAM.gov). How the rankings work · Download all 100 rows as CSV

Full ranking

Rank Contractor Net obligations Share Trend
1 $288,418,321
Rank history: #2 in FY2021, #2 in FY2022, not on the FY2024 list and #4 in FY2025; up 1 since FY2022.
2 $237,000,000
Rank history: not on the FY2021–FY2022 lists and not on the FY2024–FY2025 lists; new.
3 $135,454,000
Rank history: not on the FY2021–FY2022 lists and not on the FY2024–FY2025 lists; new.
4 $114,247,474
Rank history: #5 in FY2021, #4 in FY2022, #4 in FY2024 and not on the FY2025 list; unchanged since FY2022.
5 $97,513,528
Rank history: not on the FY2021 list, #6 in FY2022 and not on the FY2024–FY2025 lists; up 1 since FY2022.
6 $31,098,311
Rank history: #3 in FY2021, #5 in FY2022, #1 in FY2024 and #1 in FY2025; down 1 since FY2022.
7 $24,126,740
Rank history: #6 in FY2021, #7 in FY2022, #6 in FY2024 and not on the FY2025 list; unchanged since FY2022.
8 $16,247,335
Rank history: not on the FY2021 list, #10 in FY2022, #84 in FY2024 and #62 in FY2025; up 2 since FY2022.
9 $12,032,000
Rank history: not on the FY2021 list, #60 in FY2022 and not on the FY2024–FY2025 lists; up 51 since FY2022.
10 $10,455,467
Rank history: #8 in FY2021, #9 in FY2022, #27 in FY2024 and not on the FY2025 list; down 1 since FY2022.
11 $7,439,732
Rank history: #38 in FY2021, #24 in FY2022 and not on the FY2024–FY2025 lists; up 13 since FY2022.
12 $6,160,381
Rank history: #12 in FY2021, #11 in FY2022, #9 in FY2024 and not on the FY2025 list; down 1 since FY2022.
13 $6,077,136
Rank history: #19 in FY2021, #14 in FY2022, #14 in FY2024 and not on the FY2025 list; up 1 since FY2022.
14 $5,819,037
Rank history: #13 in FY2021, #13 in FY2022, #13 in FY2024 and #13 in FY2025; down 1 since FY2022.
15 $5,275,957
Rank history: #15 in FY2021, #16 in FY2022, #11 in FY2024 and #8 in FY2025; up 1 since FY2022.
16 $5,022,247
Rank history: #20 in FY2021, #17 in FY2022, #8 in FY2024 and not on the FY2025 list; up 1 since FY2022.
17 $4,988,973
Rank history: #11 in FY2021, #15 in FY2022, #15 in FY2024 and not on the FY2025 list; down 2 since FY2022.
18 $3,627,708
Rank history: #7 in FY2021, #3 in FY2022, #28 in FY2024 and not on the FY2025 list; down 15 since FY2022.
19 $3,581,309
Rank history: not on the FY2021–FY2022 lists and not on the FY2024–FY2025 lists; new.
20 $3,340,274
Rank history: not on the FY2021 list, #41 in FY2022, #33 in FY2024 and #93 in FY2025; up 21 since FY2022.
21 $3,135,908
Rank history: #37 in FY2021, #27 in FY2022, #31 in FY2024 and #10 in FY2025; up 6 since FY2022.
22 $2,700,000
Rank history: not on the FY2021–FY2022 lists and not on the FY2024–FY2025 lists; new.
23 $2,612,716
Rank history: not on the FY2021–FY2022 lists and not on the FY2024–FY2025 lists; up 190 since FY2022.
24 $2,326,616
Rank history: #16 in FY2021, #18 in FY2022, #18 in FY2024 and #14 in FY2025; down 6 since FY2022.
25 $2,275,981
Rank history: #22 in FY2021, #21 in FY2022, #25 in FY2024 and not on the FY2025 list; down 4 since FY2022.
26 $2,053,835
Rank history: #18 in FY2021, #22 in FY2022, #55 in FY2024 and #42 in FY2025; down 4 since FY2022.
27 $1,791,628
Rank history: #83 in FY2021, not on the FY2022 list, #38 in FY2024 and not on the FY2025 list; up 127 since FY2022.
28 $1,667,469
Rank history: not on the FY2021 list, #23 in FY2022 and not on the FY2024–FY2025 lists; down 5 since FY2022.
29 $1,496,744
Rank history: not on the FY2021 list, #67 in FY2022 and not on the FY2024–FY2025 lists; up 38 since FY2022.
30 $1,494,363
Rank history: #34 in FY2021, #37 in FY2022, #62 in FY2024 and #38 in FY2025; up 7 since FY2022.
31 $1,460,519
Rank history: #36 in FY2021, #39 in FY2022, #43 in FY2024 and #23 in FY2025; up 8 since FY2022.
32 $1,438,162
Rank history: not on the FY2021–FY2022 lists and not on the FY2024–FY2025 lists; new.
33 $1,354,205
Rank history: not on the FY2021–FY2022 lists, not on the FY2024 list and #72 in FY2025; new.
34 $1,352,084
Rank history: #30 in FY2021, #29 in FY2022, #26 in FY2024 and #30 in FY2025; down 5 since FY2022.
35 $1,175,663
Rank history: #27 in FY2021, #62 in FY2022, #32 in FY2024 and not on the FY2025 list; up 27 since FY2022.
36 $1,152,329
Rank history: #40 in FY2021, #52 in FY2022, #34 in FY2024 and #17 in FY2025; up 16 since FY2022.
37 $1,087,559
Rank history: #24 in FY2021, #28 in FY2022, #42 in FY2024 and #27 in FY2025; down 9 since FY2022.
38 $1,020,247
Rank history: #29 in FY2021, #35 in FY2022, #48 in FY2024 and not on the FY2025 list; down 3 since FY2022.
39 $978,314
Rank history: #26 in FY2021, #47 in FY2022, #30 in FY2024 and #19 in FY2025; up 8 since FY2022.
40 $975,766
Rank history: #43 in FY2021, #44 in FY2022, #37 in FY2024 and #35 in FY2025; up 4 since FY2022.
41 $951,082
Rank history: #9 in FY2021, #19 in FY2022, #39 in FY2024 and #36 in FY2025; down 22 since FY2022.
42 $812,386
Rank history: not on the FY2021–FY2022 lists, #67 in FY2024 and not on the FY2025 list; up 81 since FY2022.
43 $762,850
Rank history: not on the FY2021–FY2022 lists, #47 in FY2024 and #18 in FY2025; up 109 since FY2022.
44 $740,073
Rank history: #61 in FY2021, #79 in FY2022, #20 in FY2024 and not on the FY2025 list; up 35 since FY2022.
45 $738,032
Rank history: not on the FY2021 list, #61 in FY2022, #40 in FY2024 and #43 in FY2025; up 16 since FY2022.
46 $684,753
Rank history: #53 in FY2021, #36 in FY2022, #46 in FY2024 and not on the FY2025 list; down 10 since FY2022.
47 $664,232
Rank history: #54 in FY2021, #49 in FY2022 and not on the FY2024–FY2025 lists; up 2 since FY2022.
48 $661,519
Rank history: not on the FY2021–FY2022 lists, #10 in FY2024 and #12 in FY2025; new.
49 $651,651
Rank history: #33 in FY2021, #42 in FY2022, #45 in FY2024 and #41 in FY2025; down 7 since FY2022.
50
Wittenstein Inc. Through Attocube Systems GMBH
$642,840
Rank history: not on the FY2021–FY2022 lists and not on the FY2024–FY2025 lists; new.
51 $536,077
Rank history: #23 in FY2021, #20 in FY2022, #35 in FY2024 and #28 in FY2025; down 31 since FY2022.
52
Oxford Nanopore Technologies PLC
$511,610
Rank history: not on the FY2021–FY2022 lists and not on the FY2024–FY2025 lists; new.
53
Ortho-Clinical Diagnostics Singapore PTE. Ltd. Korea Branch 2 awardees, including Ortho-Clinical Diagnostics
$496,441
Rank history: #65 in FY2021, not on the FY2022 list, #95 in FY2024 and not on the FY2025 list; up 54 since FY2022.
54 $492,073
Rank history: not on the FY2021 list, #87 in FY2022 and not on the FY2024–FY2025 lists; up 33 since FY2022.
55 $457,285
Rank history: #41 in FY2021, #50 in FY2022, #57 in FY2024 and #44 in FY2025; down 5 since FY2022.
56
Emergency Physicians Medical Group P.C. 2 awardees, including Biosearch Technologies, Inc. and LGC Clinical Diagnostics Inc.
$438,325
Rank history: #57 in FY2021, not on the FY2022 list and not on the FY2024–FY2025 lists; up 105 since FY2022.
57 $399,993
Rank history: not on the FY2021–FY2022 lists, #44 in FY2024 and not on the FY2025 list; new.
58
Genomedx Biosciences Corp. Through Veracyte Labs SD Corporation
$390,000
Rank history: not on the FY2021–FY2022 lists and not on the FY2024–FY2025 lists; new.
59 $387,528
Rank history: #35 in FY2021, #46 in FY2022, #52 in FY2024 and #46 in FY2025; down 13 since FY2022.
60 $382,356
Rank history: not on the FY2021 list, #71 in FY2022, #79 in FY2024 and #77 in FY2025; up 11 since FY2022.
61 $376,880
Rank history: not on the FY2021–FY2022 lists and not on the FY2024–FY2025 lists; new.
62 $372,235
Rank history: not on the FY2021 list, #58 in FY2022, #63 in FY2024 and not on the FY2025 list; down 4 since FY2022.
63 $328,325
Rank history: not on the FY2021–FY2022 lists and not on the FY2024–FY2025 lists; new.
64 $314,914
Rank history: #51 in FY2021, #65 in FY2022, #71 in FY2024 and #67 in FY2025; up 1 since FY2022.
65 $314,363
Rank history: #44 in FY2021, #43 in FY2022, #72 in FY2024 and #57 in FY2025; down 22 since FY2022.
66 $306,649
Rank history: #56 in FY2021, not on the FY2022 list and not on the FY2024–FY2025 lists; returned.
67
Steris Corporation
$284,975
Rank history: not on the FY2021–FY2022 lists and not on the FY2024–FY2025 lists; new.
68 $270,038
Rank history: #85 in FY2021, #92 in FY2022, not on the FY2024 list and #94 in FY2025; up 24 since FY2022.
69 $266,525
Rank history: not on the FY2021 list, #69 in FY2022 and not on the FY2024–FY2025 lists; unchanged since FY2022.
70 $265,267
Rank history: #71 in FY2021, #38 in FY2022, #59 in FY2024 and #48 in FY2025; down 32 since FY2022.
71 $264,307
Rank history: #64 in FY2021, #82 in FY2022, #80 in FY2024 and #71 in FY2025; up 11 since FY2022.
72 $258,949
Rank history: #45 in FY2021, #53 in FY2022, #49 in FY2024 and #29 in FY2025; down 19 since FY2022.
73
American Type Culture Collection
$249,522
Rank history: #69 in FY2021, not on the FY2022 list and not on the FY2024–FY2025 lists; returned.
74
Olink Proteomics Inc
$246,214
Rank history: not on the FY2021–FY2022 lists and not on the FY2024–FY2025 lists; new.
75 $243,838
Rank history: #89 in FY2021, not on the FY2022 list, #29 in FY2024 and #34 in FY2025; returned.
76 $234,649
Rank history: #66 in FY2021, #78 in FY2022, #56 in FY2024 and not on the FY2025 list; up 2 since FY2022.
77
Seqirus USA Inc. Through CSL Behring L.L.C.
$223,222
Rank history: not on the FY2021–FY2022 lists and not on the FY2024–FY2025 lists; up 164 since FY2022.
78
Miraca Holdings Inc. Through Fujirebio US, Inc.
$218,441
Rank history: not on the FY2021–FY2022 lists and not on the FY2024–FY2025 lists; new.
79 $206,622
Rank history: #39 in FY2021, #84 in FY2022 and not on the FY2024–FY2025 lists; up 5 since FY2022.
80 $203,701
Rank history: not on the FY2021–FY2022 lists and not on the FY2024–FY2025 lists; up 28 since FY2022.
81 $197,075
Rank history: not on the FY2021 list, #81 in FY2022, #94 in FY2024 and #63 in FY2025; unchanged since FY2022.
82 $190,699
Rank history: not on the FY2021–FY2022 lists and not on the FY2024–FY2025 lists; new.
83 $180,146
Rank history: not on the FY2021–FY2022 lists, #75 in FY2024 and not on the FY2025 list; up 47 since FY2022.
84 $179,000
Rank history: not on the FY2021–FY2022 lists and not on the FY2024–FY2025 lists; new.
85 $176,152
Rank history: not on the FY2021–FY2022 lists and not on the FY2024–FY2025 lists; new.
86 $175,701
Rank history: not on the FY2021–FY2022 lists and not on the FY2024–FY2025 lists; new.
87 $172,457
Rank history: not on the FY2021–FY2022 lists and not on the FY2024–FY2025 lists; up 34 since FY2022.
88
Mission BIO Inc.
$166,729
Rank history: not on the FY2021–FY2022 lists and not on the FY2024–FY2025 lists; new.
89 $161,477
Rank history: not on the FY2021 list, #90 in FY2022 and not on the FY2024–FY2025 lists; up 1 since FY2022.
90
Instrumentation Laboratory Japan Co. Ltd. 2 awardees, including Werfen GMBH
$158,999
Rank history: not on the FY2021 list, #59 in FY2022, #91 in FY2024 and not on the FY2025 list; down 31 since FY2022.
91
Ahlstrom USA Inc.
$158,000
Rank history: #60 in FY2021, #54 in FY2022, #90 in FY2024 and not on the FY2025 list; down 37 since FY2022.
92 $154,745
Rank history: not on the FY2021–FY2022 lists and not on the FY2024–FY2025 lists; new.
93 $150,000
Rank history: not on the FY2021 list, #56 in FY2022 and not on the FY2024–FY2025 lists; down 37 since FY2022.
94 $150,000
Rank history: not on the FY2021–FY2022 lists, not on the FY2024 list and #51 in FY2025; new.
95 $142,036
Rank history: not on the FY2021–FY2022 lists and not on the FY2024–FY2025 lists; up 63 since FY2022.
96 $139,535
Rank history: #93 in FY2021, not on the FY2022 list, not on the FY2024 list and #80 in FY2025; up 17 since FY2022.
97 $132,776
Rank history: not on the FY2021–FY2022 lists and not on the FY2024–FY2025 lists; up 42 since FY2022.
98 $129,888
Rank history: not on the FY2021–FY2022 lists and not on the FY2024–FY2025 lists; new.
99
Tosoh Corporation Through Tosoh Bioscience, Inc.
$128,059
Rank history: #75 in FY2021, not on the FY2022 list, #92 in FY2024 and not on the FY2025 list; up 19 since FY2022.
100 $123,907
Rank history: #17 in FY2021, #88 in FY2022 and not on the FY2024–FY2025 lists; down 12 since FY2022.
Show 75 more

100 of 246 contractors listed here. See the rest on GovTribe.

How this ranking works

  • Source: every contract action FPDS records (as published on SAM.gov) in the period, as GovTribe received it.
  • Amounts are net obligations: what was obligated, less what was deobligated. Shares are of $1.14 billion obligated before deobligations, so they never pass 100%.
  • Parent companies: each action counts under the ultimate parent its award record names, or under the awardee when it names none, so no dollar counts twice. Parents of the same name (Inc., LLC and the like aside) count as one company, since FPDS records a company's parent under more than one UEI over time. GovTribe corrects a few parents and names by hand; see the corrections.
  • Fiscal year 2023 ran Oct 1, 2022 – Sep 30, 2023. The Department of Defense reports its contract actions to FPDS about 90 days late, so a fiscal year is ranked once they're in, in February, and the list doesn't change after.
  • Rank changes compare with FY2022. "New" marks a company outside that period's top 500, and "Returned" one of those that was on an earlier fiscal year's list.
  • Rank lines show each company's rank on every fiscal year's list since FY2021, #1 at the top, on a scale that gives the top of the list more room. A dashed stretch spans years it wasn't on the list. The step from FY2022 takes the color of the rank change beside it.
  • Placeholder recipients FPDS uses when it names no company ("Miscellaneous Foreign Contractors" and the like) aren't ranked.

Quick answers

Who were the top 10 PSC 6550 contractors in FY2023?

1. Abbott Laboratories ($288M), 2. Osang LLC ($237M), 3. Access Bio, Inc. ($135M), 4. Roche Holding AG ($114M), 5. Quidel Corp ($97.5M), 6. Danaher Corporation ($31.1M), 7. Compagnie Merieux Alliance ($24.1M), 8. Orasure Technologies Inc. ($16.2M), 9. Celltrion USA Inc. ($12M), 10. Thermo Electron Corporation ($10.5M).

On GovTribe

Research every contractor on this list

  • Every contract, task order and IDV they hold
  • Their subsidiaries, teammates and competitors
  • Open opportunities they're positioned for
  • Alerts when they win new work